rs375904354
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP4_StrongBP6_ModerateBS1
The NM_000168.6(GLI3):c.1242+25C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00005 in 1,560,752 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.00013 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000041 ( 0 hom. )
Consequence
GLI3
NM_000168.6 intron
NM_000168.6 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.55
Publications
0 publications found
Genes affected
GLI3 (HGNC:4319): (GLI family zinc finger 3) This gene encodes a protein which belongs to the C2H2-type zinc finger proteins subclass of the Gli family. They are characterized as DNA-binding transcription factors and are mediators of Sonic hedgehog (Shh) signaling. The protein encoded by this gene localizes in the cytoplasm and activates patched Drosophila homolog (PTCH) gene expression. It is also thought to play a role during embryogenesis. Mutations in this gene have been associated with several diseases, including Greig cephalopolysyndactyly syndrome, Pallister-Hall syndrome, preaxial polydactyly type IV, and postaxial polydactyly types A1 and B. [provided by RefSeq, Jul 2008]
GLI3 Gene-Disease associations (from GenCC):
- Greig cephalopolysyndactyly syndromeInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Laboratory for Molecular Medicine, Orphanet, Labcorp Genetics (formerly Invitae), G2P, Genomics England PanelApp, Ambry Genetics, PanelApp Australia
- Pallister-Hall syndromeInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine, G2P, Ambry Genetics, Orphanet
- polydactyly, postaxial, type A1Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- polysyndactyly 4Inheritance: AD Classification: MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet
- tibial hemimeliaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- acrocallosal syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- postaxial polydactyly type AInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -10 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BP6
Variant 7-42026174-G-A is Benign according to our data. Variant chr7-42026174-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 255417.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.000131 (20/152166) while in subpopulation AFR AF = 0.00041 (17/41438). AF 95% confidence interval is 0.000261. There are 0 homozygotes in GnomAd4. There are 10 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000131 AC: 20AN: 152166Hom.: 0 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
20
AN:
152166
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0000261 AC: 6AN: 230006 AF XY: 0.0000242 show subpopulations
GnomAD2 exomes
AF:
AC:
6
AN:
230006
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000412 AC: 58AN: 1408586Hom.: 0 Cov.: 27 AF XY: 0.0000356 AC XY: 25AN XY: 702600 show subpopulations
GnomAD4 exome
AF:
AC:
58
AN:
1408586
Hom.:
Cov.:
27
AF XY:
AC XY:
25
AN XY:
702600
show subpopulations
African (AFR)
AF:
AC:
7
AN:
32302
American (AMR)
AF:
AC:
0
AN:
43060
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
25572
East Asian (EAS)
AF:
AC:
1
AN:
38902
South Asian (SAS)
AF:
AC:
0
AN:
83590
European-Finnish (FIN)
AF:
AC:
0
AN:
52636
Middle Eastern (MID)
AF:
AC:
0
AN:
5286
European-Non Finnish (NFE)
AF:
AC:
45
AN:
1068722
Other (OTH)
AF:
AC:
5
AN:
58516
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
3
6
9
12
15
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.000131 AC: 20AN: 152166Hom.: 0 Cov.: 33 AF XY: 0.000135 AC XY: 10AN XY: 74328 show subpopulations
GnomAD4 genome
AF:
AC:
20
AN:
152166
Hom.:
Cov.:
33
AF XY:
AC XY:
10
AN XY:
74328
show subpopulations
African (AFR)
AF:
AC:
17
AN:
41438
American (AMR)
AF:
AC:
0
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3472
East Asian (EAS)
AF:
AC:
0
AN:
5186
South Asian (SAS)
AF:
AC:
0
AN:
4822
European-Finnish (FIN)
AF:
AC:
0
AN:
10614
Middle Eastern (MID)
AF:
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
AC:
3
AN:
68030
Other (OTH)
AF:
AC:
0
AN:
2094
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.515
Heterozygous variant carriers
0
1
3
4
6
7
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.